Study on Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer | Clinical Trial

Study on Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer | Clinical Trial | Right2Hope